73 related articles for article (PubMed ID: 21331615)
21. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
Frühwald MC; O'Dorisio MS; Smith L; Dai Z; Wright FA; Paulus W; Jürgens H; Plass C
Klin Padiatr; 2001; 213(4):197-203. PubMed ID: 11528554
[TBL] [Abstract][Full Text] [Related]
22. Effects of DNA methylation on galectin-3 expression in pituitary tumors.
Ruebel KH; Jin L; Qian X; Scheithauer BW; Kovacs K; Nakamura N; Zhang H; Raz A; Lloyd RV
Cancer Res; 2005 Feb; 65(4):1136-40. PubMed ID: 15734994
[TBL] [Abstract][Full Text] [Related]
23. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M
Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250
[TBL] [Abstract][Full Text] [Related]
24. Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.
Reed JE; Dunn JR; du Plessis DG; Shaw EJ; Reeves P; Gee AL; Warnke PC; Sellar GC; Moss DJ; Walker C
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):77-85. PubMed ID: 17239010
[TBL] [Abstract][Full Text] [Related]
25. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic therapy of novel tumour suppressor ZAR1 and its cancer biomarker function.
Deutschmeyer V; Breuer J; Walesch SK; Sokol AM; Graumann J; Bartkuhn M; Boettger T; Rossbach O; Richter AM
Clin Epigenetics; 2019 Dec; 11(1):182. PubMed ID: 31801617
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I.
Brebi P; Hoffstetter R; Andana A; Ili CG; Saavedra K; Viscarra T; Retamal J; Sanchez R; Roa JC
Biomarkers; 2014 May; 19(3):181-8. PubMed ID: 24787227
[TBL] [Abstract][Full Text] [Related]
28. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
29. ZAR1 knockdown promotes the differentiation of human neuroblastoma cells by suppression of MYCN expression.
Watanabe Y; Ishizuka Y; Hirano T; Nagasaki-Maeoka E; Hoshi R; Yoshizawa S; Uekusa S; Kawashima H; Sugito K; Shinohara K; Fukuda N; Nagase H; Soma M; Koshinaga T; Fujiwara K
Med Oncol; 2017 Aug; 34(9):158. PubMed ID: 28791558
[TBL] [Abstract][Full Text] [Related]
30. Variation Screening of Zygote Arrest 1(ZAR1) in Women with Recurrent Zygote Arrest During IVF/ICSI Programs.
Tian Y; Yang J; Peng Y; Chen T; Huang T; Zhang C; Zhao H
Reprod Sci; 2020 Dec; 27(12):2265-2270. PubMed ID: 32700283
[TBL] [Abstract][Full Text] [Related]
31. Expression of Rac3 in human brain tumors.
Hwang SL; Chang JH; Cheng TS; Sy WD; Lieu AS; Lin CL; Lee KS; Howng SL; Hong YR
J Clin Neurosci; 2005 Jun; 12(5):571-4. PubMed ID: 15993075
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of O6-methylguanine-DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas.
Brell M; Tortosa A; Verger E; Gil JM; Viñolas N; Villá S; Acebes JJ; Caral L; Pujol T; Ferrer I; Ribalta T; Graus F
Clin Cancer Res; 2005 Jul; 11(14):5167-74. PubMed ID: 16033832
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
34. Expression of coronin-3 (coronin-1C) in diffuse gliomas is related to malignancy.
Thal D; Xavier CP; Rosentreter A; Linder S; Friedrichs B; Waha A; Pietsch T; Stumpf M; Noegel A; Clemen C
J Pathol; 2008 Mar; 214(4):415-24. PubMed ID: 18189330
[TBL] [Abstract][Full Text] [Related]
35. Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.
Konduri SD; Srivenugopal KS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Foster DC; Kisiel W; Ali-Osman F; Kondraganti S; Lakka SS; Rao JS
Oncogene; 2003 Jul; 22(29):4509-16. PubMed ID: 12881707
[TBL] [Abstract][Full Text] [Related]
36. Hypermethylation of the CpG island of p16/CDKN2 correlates with gene inactivation in gliomas.
Fueyo J; Gomez-Manzano C; Bruner JM; Saito Y; Zhang B; Zhang W; Levin VA; Yung WK; Kyritsis AP
Oncogene; 1996 Oct; 13(8):1615-9. PubMed ID: 8895506
[TBL] [Abstract][Full Text] [Related]
37. DNA hypermethylation of zygote arrest 1 (ZAR1) in hepatitis C virus positive related hepatocellular carcinoma.
Takagi K; Fujiwara K; Takayama T; Mamiya T; Soma M; Nagase H
Springerplus; 2013 Dec; 2(1):150. PubMed ID: 23678400
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
39. Cloning and expression analysis of zygote arrest 1 (Zar1) in New Zealand white rabbits.
Wang D; Xie SY; Zhang W; Sun CX; Huang T; Wang AS; Han XL; Sun GR; Li M
J Genet; 2017 Mar; 96(1):3-8. PubMed ID: 28360383
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
